HIV tat domain improves cross-correction of human galactocerebrosidase in a gene- And flanking sequence-dependent manner

Molecular Therapy Nucleic Acids

Volumn 2, Issue OCT, 2013, Pages e130-

  Meng, Xing Li ^a   Eto, Yoshikatsu ^b   Schiffmann, Raphael ^a   Shen, Jin Song ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Corss correction; Galactocerebrosidase; Protein transduction domain

Indexed keywords

8E4 ANTIBODY; ALPHA GALACTOSIDASE; AMINO ACID; ANTIBODY; GALACTOSYLCERAMIDASE; HYBRID PROTEIN; LYSOSOME ENZYME; MANNOSE; PROTEIN; PROTEIN TRANSDUCTION DOMAIN; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DNA FLANKING REGION; ENZYME ACTIVITY; GENE SEQUENCE; GLYCOSYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN SECRETION; PROTEIN SYNTHESIS; PROTEIN TRANSPORT;

EID: 84903899842     PISSN: None     EISSN: 21622531     Source Type: Journal    
DOI: 10.1038/mtna.2013.57     Document Type: Article

References (35)

1. Suzuki, K and Suzuki, Y (1970). Globoid cell leucodystrophy (Krabbe's disease): deficiency of galactocerebroside beta-galactosidase. Proc Natl Acad Sci USA 66: 302-309.
2. Wenger, DA, Suzuki, K, Suzuki, Y, and Suzuki, K (2001). Galactosylceramide lipidosis: globoid cell leukodystrophy (Krabbe disease). In: Scriver, CR, Beaudet, AL, Sly, WS, and Valle, D (eds). The Metabolic and Molecular Bases of Inherited Disease, 8 edn. McGraw-Hill: New York. pp. 3669-3694.
3. Krivit, W, Shapiro, EG, Peters, C, Wagner, JE, Cornu, G, Kurtzberg, J et al. (1998). Hematopoietic stem-cell transplantation in globoid-cell leukodystrophy. N Engl J Med 338: 1119-1126. (Pubitemid 28227482)
4. Shen, JS, Watabe, K, Ohashi, T and Eto, Y (2001). Intraventricular administration of recombinant adenovirus to neonatal twitcher mouse leads to clinicopathological improvements. Gene Ther 8: 1081-1087. (Pubitemid 32962705)
5. .Meng, XL, Shen, JS, Watabe, K, Ohashi, T and Eto, Y (2005). GALC transduction leads to morphological improvement of the twitcher oligodendrocytes in vivo. Mol Genet Metab 84: 332-343. (Pubitemid 40386880)
6. Rafi, MA, Zhi Rao, H, Passini, MA, Curtis, M, Vanier, MT, Zaka, M et al. (2005). AAV-mediated expression of galactocerebrosidase in brain results in attenuated symptoms and extended life span in murine models of globoid cell leukodystrophy. Mol Ther 11: 734-744. (Pubitemid 40567978)
7. Lin, D, Fantz, CR, Levy, B, Rafi, MA, Vogler, C, Wenger, DA et al. (2005). AAV2/5 vector expressing galactocerebrosidase ameliorates CNS disease in the murine model of globoid-cell leukodystrophy more efficiently than AAV2. Mol Ther 12: 422-430. (Pubitemid 41150127)
8. Lin, D, Donsante, A, Macauley, S, Levy, B, Vogler, C and Sands, MS (2007). Central nervous system-directed AAV2/5-mediated gene therapy synergizes with bone marrow transplantation in the murine model of globoid-cell leukodystrophy. Mol Ther 15: 44-52. (Pubitemid 46043648)
9. Galbiati, F, Givogri, MI, Cantuti, L, Rosas, AL, Cao, H, van Breemen, R et al. (2009). Combined hematopoietic and lentiviral gene-transfer therapies in newborn Twitcher mice reveal contemporaneous neurodegeneration and demyelination in Krabbe disease. J Neurosci Res 87: 1748-1759.
10. Rafi, MA, Rao, HZ, Luzi, P, Curtis, MT and Wenger, DA (2012). Extended normal life after AAVrh10-mediated gene therapy in the mouse model of Krabbe disease. Mol Ther 20: 2031-2042.
11. Lattanzi, A, Neri, M, Maderna, C, di Girolamo, I, Martino, S, Orlacchio, A et al. (2010). Widespread enzymatic correction of CNS tissues by a single intracerebral injection of therapeutic lentiviral vector in leukodystrophy mouse models. Hum Mol Genet 19: 2208-2227.
12. Sands, MS and Davidson, BL (2006). Gene therapy for lysosomal storage diseases. Mol Ther 13: 839-849.
13. Elliger, SS, Elliger, CA, Lang, C and Watson, GL (2002). Enhanced secretion and uptake of beta-glucuronidase improves adeno-associated viral-mediated gene therapy of mucopolysaccharidosis type VII mice. Mol Ther 5(5 Pt 1): 617-626. (Pubitemid 34546092)
14. Sun, B, Zhang, H, Benjamin, DK Jr, Brown, T, Bird, A, Young, SP et al. (2006). Enhanced efficacy of an AAV vector encoding chimeric, highly secreted acid alpha-glucosidase in glycogen storage disease type II. Mol Ther 14: 822-830. (Pubitemid 44743128)
15. Xia, H, Mao, Q and Davidson, BL (2001). The HIV Tat protein transduction domain improves the biodistribution of beta-glucuronidase expressed from recombinant viral vectors. Nat Biotechnol 19: 640-644. (Pubitemid 32625434)
16. Orii, KO, Grubb, JH, Vogler, C, Levy, B, Tan, Y, Markova, K et al. (2005). Defining the pathway for Tat-mediated delivery of beta-glucuronidase in cultured cells and MPS VII mice. Mol Ther 12: 345-352. (Pubitemid 41025106)
17. Lee, KO, Luu, N, Kaneski, CR, Schiffmann, R, Brady, RO and Murray, GJ (2005). Improved intracellular delivery of glucocerebrosidase mediated by the HIV-1 TAT protein transduction domain. Biochem Biophys Res Commun 337: 701-707. (Pubitemid 41429341)
18. Higuchi, K, Yoshimitsu, M, Fan, X, Guo, X, Rasaiah, VI, Yen, J et al. (2010). Alpha-galactosidase A-Tat fusion enhances storage reduction in hearts and kidneys of Fabry mice. Mol Med 16: 216-221.
19. Shen, JS, Watabe, K, Meng, XL, Ida, H, Ohashi, T and Eto, Y (2002). Establishment and characterization of spontaneously immortalized Schwann cells from murine model of globoid cell leukodystrophy (twitcher). J Neurosci Res 68: 588-594. (Pubitemid 34575624)
20. Zhang, XY, Dinh, A, Cronin, J, Li, SC and Reiser, J (2008). Cellular uptake and lysosomal delivery of galactocerebrosidase tagged with the HIV Tat protein transduction domain. J Neurochem 104: 1055-1064. (Pubitemid 351143640)
21. Neufeld, EF (1991). Lysosomal storage diseases. Annu Rev Biochem 60: 257-280.
22. Barneveld, RA, Tegelaers, FP, Ginns, EI, Visser, P, Laanen, EA, Brady, RO et al. (1983). Monoclonal antibodies against human beta-glucocerebrosidase. Eur J Biochem 134: 585-589. (Pubitemid 13044890)
23. .Matsuki, H, Yonezawa, K, Obata, K, Iwata, K, Nakamura, H, Okada, Y et al. (2003). Monoclonal antibodies with defined recognition sequences in the stem region of CD44: detection of differential glycosylation of CD44 between tumor and stromal cells in tissue. Cancer Res 63: 8278-8283. (Pubitemid 37549479)
24. Barash, S, Wang, W and Shi, Y (2002). Human secretory signal peptide description by hidden Markov model and generation of a strong artificial signal peptide for secreted protein expression. Biochem Biophys Res Commun 294: 835-842. (Pubitemid 34687192)
25. Haberman, RP, Samulski, RJ and McCown, TJ (2003). Attenuation of seizures and neuronal death by adeno-associated virus vector galanin expression and secretion. Nat Med 9: 1076-1080. (Pubitemid 37021789)
26. Lundberg, M, Wikström, S and Johansson, M (2003). Cell surface adherence and endocytosis of protein transduction domains. Mol Ther 8: 143-150. (Pubitemid 36939305)
27. Grubb, JH, Vogler, C and Sly, WS (2010). New strategies for enzyme replacement therapy for lysosomal storage diseases. Rejuvenation Res 13: 229-236.
28. Kornfeld, S (1992). Structure and function of the mannose 6-phosphate/insulinlike growth factor II receptors. Annu Rev Biochem 61: 307-330.
29. Reczek, D, Schwake, M, Schröder, J, Hughes, H, Blanz, J, Jin, X et al. (2007). LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of betaglucocerebrosidase. Cell 131: 770-783. (Pubitemid 350087202)
30. Baranski, TJ, Faust, PL and Kornfeld, S (1990). Generation of a lysosomal enzyme targeting signal in the secretory protein pepsinogen. Cell 63: 281-291.
31. Coutinho, MF, Prata, MJ and Alves, S (2012). Mannose-6-phosphate pathway: a review on its role in lysosomal function and dysfunction. Mol Genet Metab 105: 542-550.
32. Gingold, H and Pilpel, Y (2011). Determinants of translation efficiency and accuracy. Mol Syst Biol 7: 481.
33. Pantophlet, R and Burton, DR (2006). GP120: target for neutralizing HIV-1 antibodies. Annu Rev Immunol 24: 739-769.
34. .Meng, XL, Shen, JS, Kawagoe, S, Ohashi, T, Brady, RO and Eto, Y (2010). Induced pluripotent stem cells derived from mouse models of lysosomal storage disorders. Proc Natl Acad Sci USA 107: 7886-7891.
35. Shen, JS, Meng, XL, Moore, DF, Quirk, JM, Shayman, JA, Schiffmann, R et al. (2008). Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells. Mol Genet Metab 95: 163-168.